| Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis A Cipriani, TA Furukawa, G Salanti, A Chaimani, LZ Atkinson, Y Ogawa, ... The Lancet 391 (10128), 1357-1366, 2018 | 3652 | 2018 |
| Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ... The Lancet 382 (9896), 951-962, 2013 | 3110 | 2013 |
| Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ... World psychiatry 10 (1), 52, 2011 | 2920 | 2011 |
| Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis S Leucht, C Corves, D Arbter, RR Engel, C Li, JM Davis The Lancet 373 (9657), 31-41, 2009 | 2646 | 2009 |
| Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis M Huhn, A Nikolakopoulou, J Schneider-Thoma, M Krause, M Samara, ... The Lancet 394 (10202), 939-951, 2019 | 1488 | 2019 |
| What does the PANSS mean? S Leucht, JM Kane, W Kissling, J Hamann, E Etschel, RR Engel Schizophrenia research 79 (2-3), 231-238, 2005 | 1281 | 2005 |
| Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis S Leucht, M Tardy, K Komossa, S Heres, W Kissling, G Salanti, JM Davis The Lancet 379 (9831), 2063-2071, 2012 | 1161 | 2012 |
| Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A … S Leucht, G Pitschel-Walz, D Abraham, W Kissling Schizophrenia research 35 (1), 51-68, 1999 | 1152 | 1999 |
| Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ... World psychiatry 10 (2), 138, 2011 | 1089 | 2011 |
| The effect of family interventions on relapse and rehospitalization in schizophrenia—a meta-analysis G Pitschel-Walz, S Leucht, J Bäuml, W Kissling, RR Engel Schizophrenia bulletin 27 (1), 73-92, 2001 | 1070 | 2001 |
| Opioid antagonists for alcohol dependence S Roesner, A Hackl‐Herrwerth, S Leucht, S Vecchi, M Srisurapanont, ... Cochrane database of systematic reviews, 2010 | 1044 | 2010 |
| Physical illness and schizophrenia: a review of the literature S Leucht, T Burkard, J Henderson, M Maj, N Sartorius Acta Psychiatrica Scandinavica 116 (5), 317-333, 2007 | 968 | 2007 |
| Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies CU Correll, S Leucht, JM Kane American Journal of psychiatry 161 (3), 414-425, 2004 | 928 | 2004 |
| Clinical implications of brief psychiatric rating scale scores S Leucht, JM Kane, W Kissling, J Hamann, EVA Etschel, R Engel The British Journal of Psychiatry 187 (4), 366-371, 2005 | 901 | 2005 |
| Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis C Rummel-Kluge, K Komossa, S Schwarz, H Hunger, F Schmid, ... Schizophrenia research 123 (2-3), 225-233, 2010 | 885 | 2010 |
| Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis A Cipriani, X Zhou, C Del Giovane, SE Hetrick, B Qin, C Whittington, ... The Lancet 388 (10047), 881-890, 2016 | 824 | 2016 |
| New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis S Leucht, K Wahlbeck, J Hamann, W Kissling The Lancet 361 (9369), 1581-1589, 2003 | 813 | 2003 |
| Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane American Journal of Psychiatry 160 (7), 1209-1222, 2003 | 722 | 2003 |
| A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia S Leucht, K Komossa, C Rummel-Kluge, C Corves, H Hunger, F Schmid, ... American Journal of Psychiatry 166 (2), 152-163, 2009 | 702 | 2009 |
| Clozapine versus other atypical antipsychotics for schizophrenia CA Lobos, K Komossa, C Rummel‐Kluge, H Hunger, F Schmid, ... Cochrane Database of Systematic Reviews, 2010 | 694* | 2010 |
